T-Therapeutics

About:

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Website: https://t-therapeutics.com/

Top Investors: Cambridge Innovation Capital, F-Prime Capital, Digitalis Ventures, Sofinnova Partners, University of Cambridge Enterprise

Description:

T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .